- Home
- CWEN vs ALVO Comparison
CWEN vs ALVO Comparison
Compare CWEN & ALVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CWEN
- ALVO
- Stock Information
- Founded
- CWEN 2012
- ALVO 2013
- Country
- CWEN United States
- ALVO Luxembourg
- Employees
- CWEN N/A
- ALVO N/A
- Industry
- CWEN Electric Utilities: Central
- ALVO Biotechnology: Pharmaceutical Preparations
- Sector
- CWEN Utilities
- ALVO Health Care
- Exchange
- CWEN Nasdaq
- ALVO Nasdaq
- Market Cap
- CWEN 3.2B
- ALVO 3.5B
- IPO Year
- CWEN 2013
- ALVO N/A
- Fundamental
- Price
- CWEN $28.36
- ALVO $12.39
- Analyst Decision
- CWEN Buy
- ALVO Buy
- Analyst Count
- CWEN 8
- ALVO 1
- Target Price
- CWEN $31.63
- ALVO $18.00
- AVG Volume (30 Days)
- CWEN 1.0M
- ALVO 79.6K
- Earning Date
- CWEN 10-30-2024
- ALVO 11-13-2024
- Dividend Yield
- CWEN 5.98%
- ALVO N/A
- EPS Growth
- CWEN 124.49
- ALVO N/A
- EPS
- CWEN 1.04
- ALVO N/A
- Revenue
- CWEN $1,364,000,000.00
- ALVO $393,919,000.00
- Revenue This Year
- CWEN $9.51
- ALVO $382.28
- Revenue Next Year
- CWEN $8.34
- ALVO $50.44
- P/E Ratio
- CWEN $27.37
- ALVO N/A
- Revenue Growth
- CWEN 2.33
- ALVO 517.92
- 52 Week Low
- CWEN $20.63
- ALVO $9.00
- 52 Week High
- CWEN $30.92
- ALVO $18.00
- Technical
- Relative Strength Index (RSI)
- CWEN 55.59
- ALVO 33.54
- Support Level
- CWEN $27.68
- ALVO $12.58
- Resistance Level
- CWEN $27.89
- ALVO $13.14
- Average True Range (ATR)
- CWEN 0.81
- ALVO 0.46
- MACD
- CWEN 0.15
- ALVO -0.16
- Stochastic Oscillator
- CWEN 86.25
- ALVO 2.48
About CWEN Clearway Energy Inc. Class C
Clearway Energy Inc is a publicly-traded energy infrastructure investor with a focus on investments in clean energy and owner of modern, sustainable and long-term contracted assets across North America. The company segments its operations into conventional power generation, renewables and thermal divisions.
About ALVO Alvotech
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to proven treatments for various diseases.